ENTITY
Pixium Vision Sa

Pixium Vision Sa (PIX FP)

37
Analysis
Health CareFrance
Pixium Vision SA develops retinal implant systems. The Company develops epi-retinal and sub-retinal implant systems to treat patients who have lost their sight, with the intention of improving their vision and enabling them to lead more independent lives. Pixium Vision markets its systems throughout Europe.
more
Refresh
27 Jan 2020 16:18Issuer-paid

Pixium Vision - US feasibility study now underway

On 13 January Pixium Vision announced the first implantation of the Prima system in the US, as part of its US feasibility trial in five patients...

Share
07 Nov 2019 20:10Issuer-paid

Pixium Vision - Pixium to raise up to €10m to advance Prima

Pixium Vision announced on 6 November a financing agreement with a US-based investor, European Select Growth Opportunities Fund (ESGO) for the...

Share
28 Oct 2019 19:55Issuer-paid

Pixium Vision - Building feasibility data on way to pivotal study

Patients in the ongoing, five-patient European feasibility trial on Prima are starting to use the second-generation Prima 2 glasses, which may...

Share
09 Aug 2018 15:16Issuer-paid

Pixium Vision - H118 update reflects continued Prima progress

Pixium’s Prima sub-retinal wireless implant continues to advance through human feasibility trials. The EU study recently reached full enrolment and...

Share
08 Mar 2018 16:33Issuer-paid

Pixium Vision - Focus shifts to Prima as human trials proceed

Pixium Vision is developing Prima, a potentially breakthrough wireless sub-retinal implant that generates electrical impulses at the retinal...

Share
x